News
BioConnection and Prestige Biologics
We noticed that various channels shared information about the legal proceedings between BioConnection B.V. and Prestige Biologics Co. Limited: On 11 March 2025, the Dutch court ruled in favor of BioConnection in an inspection procedure against Prestige Biologics.We...
BioConnection and Prestige Biologics
We noticed that various channels shared information about the legal proceedings between BioConnection B.V. and Prestige Biologics Co. Limited: On 11 March 2025, the Dutch court ruled in favor of BioConnection in an inspection procedure against Prestige Biologics.We...
Successful IGJ inspection completed
We are proud to share that last week BioConnection successfully completed a three-day inspection by the Healthcare and Youth Inspectorate (IGJ),...
BioConnection appoints Dr. Gary M. Phillips as the new Chairman of the Supervisory Board
Oss, NL August 26, 2024 BioConnection is pleased to announce the appointment of Dr. Gary M. Phillips as the new Chairman of the Supervisory Board....
BioConnection Receives European CMO of the Year Award 2024 in (Bio)pharmaceuticals
BioConnection is excited to share that we’ve been named the European Company of the Year in Biopharmaceutical Contract Manufacturing 2024 by Pharma...
Strategic partnership AGC Biologics and BioConnection
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and BioConnection, a specialized...
Announcement: Richard Sewalt new Chief Commercial Officer (CCO) at BioConnection
Oss, NL September 2, 2024 We are excited to announce that Richard Sewalt has joined BioConnection as our new Chief Commercial Officer (CCO). With...
BioConnection congratulates BioLineRx with their FDA approval of Aphexda
BioConnection congratulates BioLineRx with their FDA approval of Aphexda. We are proud that we have been able to support BioLineRx since the start...